These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 24693875

  • 1. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
    Zhou J, Guo D, Zhang Y, Wu W, Ran H, Wang Z.
    ACS Appl Mater Interfaces; 2014 Apr 23; 6(8):5566-76. PubMed ID: 24693875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus.
    Zhang Y, Zhou J, Guo D, Ao M, Zheng Y, Wang Z.
    Int J Nanomedicine; 2013 Apr 23; 8():3745-56. PubMed ID: 24124363
    [Abstract] [Full Text] [Related]

  • 4. Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.
    Liu J, Xu J, Zhou J, Zhang Y, Guo D, Wang Z.
    Int J Nanomedicine; 2017 Apr 23; 12():1113-1126. PubMed ID: 28223802
    [Abstract] [Full Text] [Related]

  • 5. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW, Wang SS, Tsai WJ.
    Biomaterials; 2008 Jan 23; 29(2):228-37. PubMed ID: 17953984
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z, Xiong F, He J, Dai X, Wang G.
    Eur J Pharm Biopharm; 2016 Dec 23; 109():24-34. PubMed ID: 27569030
    [Abstract] [Full Text] [Related]

  • 8. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: an in vitro thrombolysis study.
    Wang SS, Chou NK, Chung TW.
    J Biomed Mater Res A; 2009 Dec 23; 91(3):753-61. PubMed ID: 19051299
    [Abstract] [Full Text] [Related]

  • 9. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T, Yu X, Carbone EJ, Nelson C, Kan HM, Lo KW.
    Int J Pharm; 2014 Nov 20; 475(1-2):547-57. PubMed ID: 25194353
    [Abstract] [Full Text] [Related]

  • 10. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy.
    Shen JM, Gao FY, Yin T, Zhang HX, Ma M, Yang YJ, Yue F.
    Pharmacol Res; 2013 Apr 20; 70(1):102-15. PubMed ID: 23376353
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
    Mosafer J, Teymouri M.
    Artif Cells Nanomed Biotechnol; 2018 Sep 20; 46(6):1146-1155. PubMed ID: 28789586
    [Abstract] [Full Text] [Related]

  • 12. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
    Jose S, Sowmya S, Cinu TA, Aleykutty NA, Thomas S, Souto EB.
    Eur J Pharm Sci; 2014 Oct 15; 63():29-35. PubMed ID: 25010261
    [Abstract] [Full Text] [Related]

  • 13. Development of facile drug delivery platform of ranibizumab fabricated PLGA-PEGylated magnetic nanoparticles for age-related macular degeneration therapy.
    Yan J, Peng X, Cai Y, Cong W.
    J Photochem Photobiol B; 2018 Jun 15; 183():133-136. PubMed ID: 29704861
    [Abstract] [Full Text] [Related]

  • 14. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J, Han L, Qin J, Ru G, Li R, Wu L, Cui D, Yang P, He Y, Wang J.
    ACS Appl Mater Interfaces; 2015 Jul 22; 7(28):15430-41. PubMed ID: 26111015
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J.
    Eur J Pharm Sci; 2012 Apr 11; 45(5):632-8. PubMed ID: 22248882
    [Abstract] [Full Text] [Related]

  • 16. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S, Sahoo SK.
    Eur J Pharmacol; 2011 Nov 30; 670(2-3):372-83. PubMed ID: 21951969
    [Abstract] [Full Text] [Related]

  • 17. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N, Jackson TL, Elsaid Z, Alqathama A, Somavarapu S.
    Mol Pharm; 2016 Sep 06; 13(9):2923-40. PubMed ID: 27286558
    [Abstract] [Full Text] [Related]

  • 18. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y, Xie XY, Mei XG.
    Drug Deliv; 2016 Sep 06; 23(3):787-93. PubMed ID: 24870204
    [Abstract] [Full Text] [Related]

  • 19. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, Sun Y, Wu Y, Chen Y, Kong W.
    Int J Nanomedicine; 2013 Sep 06; 8():1141-54. PubMed ID: 23658482
    [Abstract] [Full Text] [Related]

  • 20. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan 06; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.